Immupharma PLC still confident on Lupuzor’s future – 19th April 2018

23rd April 2018 - 10:31 am

ImmuPharma PLC (LON:IMM) CEO Dimitri Dimitriou and chairman Tim McCarthy discuss with Proactive Investors the top-line results from their phase III trial of the drug Lupuzor.

Share this article